|
| Press Releases |
|
 |
|
| Wednesday, March 23, 2022 |
|
|
Alset International Ltd establishes Alset Mining Pte Ltd to embark on cryptocurrency mining activities |
| Singapore Exchange-listed Alset International Ltd (SGX Stock Code: 40V) ("Alset", the "Company" or together with its subsidiaries, the "Group) wishes to announce that the Company has plans to embark on cryptocurrency mining business through its subsidiary Alset Mining Pte. Ltd. ("Alset Mining"). more info >> |
|
| Monday, February 21, 2022 |
|
|
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option |
| Alset Capital Acquisition Corp. (the "Company") announced on February 3, 2022 the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering"). more info >> |
|
| Monday, October 5, 2020 |
|
|
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. |
| Document Security Systems, Inc. today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") has formed a new wholly owned subsidiary, Innate Immune, Inc. ("Innate Immune"), to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. more info >> |
|
| Friday, September 18, 2020 |
|
|
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance |
| Document Security Systems, Inc. (NYSE American: DSS) today announced its wholly owned subsidiary Impact BioMedical, Inc., through its subsidiary Global BioLife, Inc., completed efficacy testing of its proprietary 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. more info >> |
|
| Friday, July 31, 2020 |
|
|
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. more info >> |
|
| Wednesday, June 24, 2020 |
|
|
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. more info >> |
|
| Wednesday, June 17, 2020 |
|
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and Discovery Group Sciences ("GRDG"), conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc. ("Vilotos"), was published in the peer-reviewed scientific journal Molecules on June 11, 2020. more info >> |
|
| Monday, June 1, 2020 |
|
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc., would like to update its stakeholders on its suite of antiviral and medical technologies. more info >> |
|
| Friday, April 24, 2020 |
|
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts |
| SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, co-owned with its partners, is valued at USD 592 Million (SGD 841 Million). Impact Biomedical's effective ownership of 64.53% in the suite of technologies equates to a value of USD 382 Million (SGD 542 Million). more info >> |
|
| Wednesday, March 18, 2020 |
|
|
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak |
| Singapore Exchange-listed Singapore eDevelopment Limited has announced that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. ("GRDG"), recently conducted molecular docking studies, utilizing advanced computational models, which indicate Linebacker and Equivir successfully inhibit infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Scandium Mining Releases Updated Presentation Showcasing Its Only Shovel-Ready Primary Scandium Deposit
Mar 24, 2026 20:29 HKT/SGT
|
|
|
登頂 AAA！國泰君安國際MSCI ESG評級攀行業巔峰 鑄就可持續發展標杆
Mar 24, 2026 20:27 HKT/SGT
|
|
|
登顶AAA！国泰君安国际MSCI ESG评级攀行业巅峰 铸就可持续发展标杆
Mar 24, 2026 20:17 HKT/SGT
|
|
|
Baguio Green Group (Stock Code: 01397) Announces 2025 Annual Results, Profit surges 72% to HK$97 million, Hits historical high since listing
Mar 24, 2026 20:02 HKT/SGT
|
|
|
碧瑶绿色集团（股份代号：01397）公布2025年全年业绩 纯利跃升72%至9,700万港元 创上市新高
Mar 24, 2026 19:53 HKT/SGT
|
|
|
国泰君安国际保荐凯乐士科技 助力综合智能场内物流机器人龙头扬帆远航
Mar 24, 2026 19:40 HKT/SGT
|
|
|
國泰君安國際保薦凱樂士科技 助力綜合智能場內物流機器人龍頭揚帆遠航
Mar 24, 2026 19:32 HKT/SGT
|
|
|
USPA Global 與 ESPN 擴大合作關係，攜手克里斯·福勒（Chris Fowler）共同呈現 2026 年高分級馬球錦標賽
Mar 24, 2026 19:00 HKT/SGT
|
|
|
USPA Global 与 ESPN 深化合作，携手克里斯·福勒共同呈现 2026 年高目标马球锦标赛
Mar 24, 2026 19:00 HKT/SGT
|
|
|
USPA Global and ESPN Expand Relationship with Chris Fowler for 2026 High-Goal Polo Championships
Mar 24, 2026 19:00 HKT/SGT
|
|
|
中國抗體（03681.HK）2025年度虧損同比下降約43.3% 管線開發取得重大進展
Mar 24, 2026 18:11 HKT/SGT
|
|
|
SinoMab (03681.HK) Achieves Approximately 43.3% Year-over-Year Decrease in Annual Losses for 2025, Marking Significant Progress in Pipeline Advancement
Mar 24, 2026 17:53 HKT/SGT
|
|
|
中国抗体（03681.HK）2025年度亏损同比下降约43.3% 管线开发取得重大进展
Mar 24, 2026 17:44 HKT/SGT
|
|
|
HIES introduces plant-based lubricant that reduces air compressor lifecycle CO(2) emissions by 40%
Mar 24, 2026 18:07 JST
|
|
|
同仁堂醫養（02667.HK）基石鎖定逾46% "百年中醫第一股"認購進入最後倒計時
Mar 24, 2026 15:25 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
